Infinity Pharmaceuticals, Inc. Asset Impairment Charges
Infinity Pharmaceuticals, Inc. reported Asset Impairment Charges of $800.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2018-03-15
- Infinity Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2012-12-31 was $40.00K.
- Infinity Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2012-09-30 was $0.00.
- Infinity Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2010-12-31 was -$200.00.
- Infinity Pharmaceuticals, Inc. asset impairment charges for fiscal 2016 was $800.00K.
- Infinity Pharmaceuticals, Inc. asset impairment charges for fiscal 2012 was $161.00K.
- Infinity Pharmaceuticals, Inc. asset impairment charges for fiscal 2010 was $311.00K.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month | Asset Impairment Charges 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $800.00K 10-K · filed 2018-03-15 | ||||
| 2012-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $40.00K derived: sum of 2 quarters · filed 2015-02-24 | $161.00K 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $121.00K 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $121.00K 10-Q · filed 2013-08-08 | ||||
| 2010-12-31 | -$200.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | $311.00K 10-K · filed 2013-03-05 | $311.20K 10-K · filed 2012-03-13 | ||
| 2010-09-30 | $311.20K 10-Q · filed 2011-11-08 |